Vitamin B2 Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

Corneal Crosslinking for Treatment of Corneal Neovascularization
Condition:   Corneal Neovascularization Interventions:   Combination Product: 30 minute photoactivation of riboflavin 0.1%;   Combination Product: 10 minute photoactivation of riboflavin 0.1% Sponsors:   Price Vision Group;   Cornea Research Foundation of America Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2021 Category: Research Source Type: clinical trials